Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma

Cancer Research

Volumn 74, Issue 4, 2014, Pages 1005-1010

  Guest, Rachel V ^a   Boulter, Luke ^a,b   Kendall, Timothy J ^b   Minnis Lyons, Sarah E ^a   Walker, Robert ^a   Wigmore, Stephen J ^c   Sansom, Owen J ^d   Forbes, Stuart J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BACTERIAL PROTEINS; BILIARY TRACT; CELL LINEAGE; CELL TRACKING; CELL TRANSFORMATION, NEOPLASTIC; CHOLANGIOCARCINOMA; GENES, P53; GENES, REPORTER; HEPATOCYTES; KERATIN-19; LIVER NEOPLASMS; LUMINESCENT PROTEINS; MICE; MICE, TRANSGENIC; STEM CELLS;

EID: 84894229721     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-1911     Document Type: Article

References (20)

1. Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, Khan SA, et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001;48: 816-20.
2. Witjes CDM, Karim-Kos HE, Visser O, de Vries E, Ijzermans JNM, de Man RA, et al. Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival. HPB 2012;14: 777-81.
3. Ishak KG, Anthony PP, Sobin LH. Histological typing of tumours of the liver. WHO International Classification of Tumours. Berlin: Springer Verlag; 1994.
4. Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321-7.
5. Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, Smout M, et al. Liver fluke induces cholangiocarcinoma. PloS Med 2007;4: e201.
6. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combined hepatocellular-cholangiocarcinoma. A histologic and immuno-histochemical study. Cancer 1985;55:124-35.
7. Komuta M, Spee B, Vander Borght S, De Vos R, Verslype C, Aerts R, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 2008;47: 1544-56.
8. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 2012;57:69-76.
9. Fan B, Malato Y, Calvisi DF, Naqvi S, Razumilava N, Ribback S, et al. Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Investig 2012;122:2911-5.
10. Sekiya S, Suzuki A. Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes. J Clin Investig 2012;122: 3914-8.
11. Zong Y, Pamikkar A, Xu J, Antoniou A, Raynaud P, Lemaigre F, et al. Notch signaling controls liver development by regulating biliary differentiation. Development 2009;136:1727-39.
12. Yanger K, Zong Y, Maggs LR, Shapira SN, Maddipati R, Aiello NM, et al. Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes Dev 2013;27:719-24.
13. Boulter L, Govaere O, Bird TG, Radulescu S, Aucott RL, Van Rooijen N, et al. Macrophage derived Wnt signalling opposes Notch signalling in a NUMB mediated manner to specify HPC fate in chronic liver disease in liver and mouse. Nat Med 2012;18:572-9.
14. Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, Yu W, et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet 2012;44:690-3.
15. Khan SA, Thomas HC, Toledano MB, Cox IJ, Taylor-Robinson SD. p53 Mutations in human cholangiocarcinoma: a review. Liver Int 2005;25: 704-16.
16. Yeh C-N, Maitra A, Lee K-F, Jan Y-Y, Chen M-F. Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarci-noma. Carcinogenesis 2004;25:631-6.
17. Komuta M, Govaere O, Vandecaveye V, Akiba J, Van Steenbergen W, Verslype C, et al. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology 2012;55: 1876-88.
18. Holczbauer A, Factor VM, Andersen JB, Marquardt JU, Kleiner D, Raggi C, et al. Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. Gastroenterology 2013;145:221-31.
19. Zender S, Nickeleit I, Wuestefeld T, Sorensen I, Dauch D, Bozko P, et al. A critical role for notch signaling in the formation of cholangiocellular carcinomas. Cancer Cell 2013;23:784-95.
20. Dill MT, Tornillo L, Fritzius T, Terracciano L, Semela D, Bettler B, et al. Constitutive notch2 signaling induces hepatic tumors in mice. Hepa-tology 2013;57:1607-19.